Article
A surrogate marker to detect nucleophosnim (NPM1) gene mutations in the cytoplasm of acute myeloid leukemia (AML) blast cells in 30 adult Iraqi patients.
Annals of Saudi medicine - 1 Jan 2000
Al-Husseinawi Ethar Kadhim
Abstract excerpt
BACKGROUND AND OBJECTIVES: Acute myeloid leukemia (AML) with mutated nucleophosmin (NPM) gene has distinctive clinical and molecular features, and enormous advances have been achieved in the methods of diagnosing this new entity. This prospective study was designed to detect the mutant NPM protein using immunohistochemical staining in AML patients and to evaluate its application as a surrogate marker for NPM1...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
